Komori
Cross Marketing Group (3675) · InitiativeWorsened

Streamlining and Consolidation of Unprofitable Sites in the Overseas Research Business and Organizational Restructuring

First written in FY2019. 7 of 17 entries say "Worsened", first in FY2024-Q1. Latest entry: FY2026.

17entries
7years
4from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2019RestatedFY2022-Q3 – FY2022RestatedFY2024-Q22020: 120202021: 320212022: 320222023: 120232024: 120242025: 220252026: 62026
Same theme, other companies
Structural Reform in Seven Overseas MarketsA theme 10 companies write about · 1 as a headwind · 9 as a tailwind

Cross Marketing Group moved to the "Worse" side of this theme in 2026.

The whole theme swung hardest in 2026: 2 of 7 companies on the "Worse" side.

0 other companies' latest entry also says "Worsened".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026WorsenedAnnual report

    「Overseas revenue was ¥4,823 million, down 2.1% from the previous fiscal year, as the main market, the United States, secured higher revenue but the United Kingdom, India and Indonesia struggled, among other factors.」

    While the policy of restoring the overseas research business continues, overseas sales declined for the full year due to difficulties in the United Kingdom, India and Indonesia.
  2. FY2026-H1WorsenedAnnual report

    「At the Kadence Group, which operates the overseas business, sales were ¥2,376 million, down 10.0% year on year, as difficulties in the United Kingdom, India and Indonesia outweighed modest revenue growth in the core US market.」

    Regarding the restoration of the overseas research business and restructuring of its earnings model, the United Kingdom, India and Indonesia struggled while the United States posted modest revenue growth, resulting in a 10.0% decline in overseas sales. Performance differences among locations have widened.
  3. FY2025ReframedAnnual report

    「Domestic operating companies centred on Cross Marketing Inc. have seen firm research demand from client companies despite the uncertain economic environment, with revenue increasing on strong performance in the core online research business. At the Kadence Group, which operates the overseas business, revenue increased substantially as research demand recovered at its core North American locations. Meanwhile, the insight business saw revenue decline as locations in Indonesia and Singapore struggled.」

    In the restoration of the overseas research business, revenue growth driven by recovering demand at North American locations was reported, while difficulties at the Indonesian and Singapore locations persisted in the insight business, resulting in divergent performance by location.
  4. FY2025-H1MitigatedAnnual report

    「Research demand recovered at Kadence Group's overseas operations, including those in North America and India, resulting in higher revenue.」

    As part of the restoration of the overseas locations, research demand has recovered at locations in North America and India, and some overseas businesses have returned to revenue growth.
  5. FY2024-Q2RestatedAnnual report

    「At the Kadence Group, which operates the overseas business, post-pandemic demand had run its course, resulting in a substantial year-on-year decline in sales.」

    At the Kadence Group, the substantial decline in overseas sales resulting from the end of the post-pandemic concentration of demand has continued to be reported from the previous quarter.
  6. FY2024-Q1WorsenedAnnual report

    「At the overseas locations of the Kadence Group, the wave of concentrated demand that emerged after the pandemic, particularly in North America, had run its course, resulting in a substantial year-on-year decline in sales.」

    The overseas research business has been described as experiencing a substantial year-on-year decline in sales at its overseas locations as concentrated demand centred on North America after the pandemic had run its course.
  7. FY2022Cited as achievedAnnual report

    「The Company determined that it was essential to concentrate management resources in the Kadence Group, resume efforts to expand the business and strengthen its earnings base, and consequently carried out this share transfer.」

    The transfer of shares in 4 overlapping and unprofitable overseas subsidiaries and others, together with the concentration of management resources in the Kadence Group, has been confirmed in the full-year discontinued operations note as a reorganisation that has been completed.
  8. FY2022-Q3RestatedAnnual report

    「Although some overseas operating companies have been affected by the spread of COVID-19 variants, economic conditions are recovering in each country, and the effect of measures such as fixed-cost reductions pursued since the previous year has enabled the overseas business as a whole to continue contributing to earnings.」

    Although some overseas locations continue to be affected by COVID-19 variants, the recovery in economic conditions and the effects of fixed-cost reductions have enabled the overseas business as a whole to continue contributing to earnings.
  9. FY2022-Q2AdvancedAnnual report

    「Among the overseas subsidiaries, those subject to the share transfer, including MKT, operate mainly in India and Singapore, and their areas of operation overlap with those of the Kadence Group, whose shares were acquired in 2014. In addition, these subsidiaries have continued to report operating losses in the most recent fiscal year, and the difficult external environment is expected to continue. The Company therefore determined that it was essential to concentrate management resources in the Kadence Group, resume efforts to expand the business and strengthen its earnings base, and consequently carried out this share transfer.」

    The share transfer of overseas subsidiaries with overlapping operations in unprofitable regions was completed on 30 November 2021, implementing a specific reorganisation that concentrated management resources in the Kadence Group.
  10. FY2022-Q1RestatedAnnual report

    「Although some overseas locations have not progressed as expected in securing and executing certain projects, the overseas business as a whole has remained solid, including the recognition of large projects in the United States.」

    In connection with the reorganisation and restoration of overseas locations, delays in projects at some locations remain, while the overseas business as a whole, including large US projects, has been described as solid.
  11. FY2021AdvancedAnnual report

    「As part of its global strategy, the Company will improve efficiency by consolidating and integrating existing locations, make growth investments in the United States, its largest market, and explore the possibility of expanding into currently undeveloped areas, including Asia and Europe.」

    The policy for restoring the overseas research business has taken concrete shape through efficiency improvements from consolidating and integrating existing locations, growth investment in the United States, and consideration of undeveloped markets in Asia and Europe.
  12. FY2020ReframedAnnual report

    「To achieve continued growth across the Group, the Company believes it is necessary to restore the overseas research business locations, identify the businesses that will serve as the pillars of future growth, and continue investing in them.」

    The description has shifted from consolidating and integrating unprofitable locations and rebuilding the organisational structure to restoring overseas locations affected by the pandemic and investing in future growth pillars.
  13. FY2019First statedAnnual report

    「In 2019, the Company proceeded with the consolidation and integration of unprofitable locations in each region of its overseas research business and also reviewed its personnel allocation.」

    The reorganisation of the overseas research business, combining the consolidation and integration of unprofitable locations with a review of personnel allocation, is identified explicitly for the first time as a separate management issue.
Moved together

"Revenue and profit growth in the Research Business" moved the same way as this thread, in the same document, in 8 of its 17 moves.

887766★123456
  1. ★This thread
  2. 1Revenue and profit growth in the Research Business8×
  3. 2Profit pressure from locations that are not contributing to earnings8×
  4. 3Political, Economic, Social and Intellectual Property Risks from Overseas Expansion7×
  5. 4Changes in Important Affiliates and Higher Borrowings to Fund M&A7×
  6. 5Thorough cost management and expense control6×
  7. 6Decrease in Liabilities and Increase in Net Assets6×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Cross Marketing Group yet. It last moved in the Earnings presentation of 2026-08-24: "Worsened".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Streamlining and Consolidation of Unprofitable Sites in the Overseas Research Business and Organizational Restructuring | Cross Marketing Group Inc. (3675) | Komori